Akèy › Maladi Alzheimer
Etid klinik pou Maladi Alzheimer ap rekrite nan Etazini
236 etid pou Maladi Alzheimer ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA26 etid
- Orlando, FL25 etid
- St. Louis, MO22 etid
- New York City, NY21 etid
- Miami, FL20 etid
- Tampa, FL17 etid
- Atlanta, GA16 etid
- Philadelphia, PA15 etid
- Phoenix, AZ15 etid
- The Villages, FL15 etid
- Los Angeles, CA14 etid
- Indianapolis, IN14 etid
- West Palm Beach, FL13 etid
- San Diego, CA12 etid
- Houston, TX12 etid
- Dallas, TX12 etid
- Newton, MA12 etid
- Irvine, CA11 etid
- Chicago, IL11 etid
- Baltimore, MD10 etid
- Seattle, WA10 etid
- Portland, OR10 etid
- San Antonio, TX10 etid
- Pittsburgh, PA10 etid
- Nashville, TN10 etid
- Deltona, FL10 etid
- Austin, TX10 etid
- Toms River, NJ9 etid
- Cape Coral, FL9 etid
- New Haven, CT8 etid
- Durham, NC8 etid
- Las Vegas, NV8 etid
- Farmington Hills, MI8 etid
- Long Beach, CA8 etid
- Queens, NY8 etid
- Boca Raton, FL8 etid
- Jacksonville, FL8 etid
- Providence, RI8 etid
- Charlotte, NC8 etid
- Columbus, OH7 etid
Pa eta
- Alabama8 etid
- Arizona23 etid
- Ayiti3 etid
- Colorado13 etid
- Connecticut12 etid
- Distrik Columbia5 etid
- Florid51 etid
- Georgia24 etid
- Illinois19 etid
- Indiana16 etid
- Kalifòni48 etid
- Kansas7 etid
- Lwizyàn8 etid
- Maryland13 etid
- Massachusetts45 etid
- Michigan15 etid
- Minnesota9 etid
- Mississippi5 etid
- Missouri28 etid
- Nevada8 etid
- New Jersey25 etid
- New York37 etid
- North Carolina21 etid
- Ohio17 etid
- Oklahoma6 etid
- Oregon11 etid
- Pennsylvania24 etid
- Rhode Island8 etid
- South Carolina4 etid
- Tennessee16 etid
- Texas40 etid
- Utah5 etid
- Virginia12 etid
- Washington17 etid
- Wisconsin6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 a 110 · Tout sèks · Mizajou Sep 30, 2026 · NCT07099053DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau
Ap rekriteFaz 1Volontè an sante akeyi
Laj 40 a 65 · Tout sèks · Mizajou Sep 30, 2026 · NCT07142278A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06540833The Gut - PRO Study
Ap rekriteFaz 1Volontè an sante akeyi
Laj 60 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07413744A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 28, 2026 · NCT06937229Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 28, 2026 · NCT07794670A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Ap rekriteFaz 4
Laj 50 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07633470Dominantly Inherited Alzheimer Network (DIAN)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT00869817A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Sep 24, 2026 · NCT07780383A Study of LY3439539 in Participants With Alzheimer's Disease
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT07598370Combating Alzheimer's Through Sleep and Exercise
Ap rekriteVolontè an sante akeyi
Laj 55 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT04855630Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
Ap rekriteFaz 1/2
Laj 50 a 86 · Tout sèks · Mizajou Sep 23, 2026 · NCT07651319Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation
Ap rekriteVolontè an sante akeyi
Laj 50 a 100 · Tout sèks · Mizajou Sep 23, 2026 · NCT06094192A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07688213Predicting Pre-dementia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07516119A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352Music for Pain and Dementia
Ap rekrite
Laj 50 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT07602283Microbiome in Aging of Gut and Brain
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07799402PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05456503Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05048966Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Ap rekriteFaz 2
Laj 55 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06847321A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Ap rekriteFaz 1/2
Laj 50 a 90 · Tout sèks · Mizajou Sep 18, 2026 · NCT07599670Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.